These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 21378109

  • 1. Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).
    Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K.
    Rheumatology (Oxford); 2011 Aug; 50(8):1390-4. PubMed ID: 21378109
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.
    Foeldvari I, Nielsen S, Kümmerle-Deschner J, Espada G, Horneff G, Bica B, Olivieri AN, Wierk A, Saurenmann RK.
    J Rheumatol; 2007 May; 34(5):1146-50. PubMed ID: 17343318
    [Abstract] [Full Text] [Related]

  • 3. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
    Kump LI, Castañeda RA, Androudi SN, Reed GF, Foster CS.
    Ophthalmology; 2006 Oct; 113(10):1874-7. PubMed ID: 16884776
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
    Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA.
    Am J Ophthalmol; 2007 May; 143(5):840-846. PubMed ID: 17362866
    [Abstract] [Full Text] [Related]

  • 11. Etanercept and uveitis in patients with juvenile idiopathic arthritis.
    Schmeling H, Horneff G.
    Rheumatology (Oxford); 2005 Aug; 44(8):1008-11. PubMed ID: 15855187
    [Abstract] [Full Text] [Related]

  • 12. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F, Balzarin M, Falcini F, Martini G, Alessio M, Cimaz R, Cimino L, Zannin ME.
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [Abstract] [Full Text] [Related]

  • 13. Rituximab for noninfectious uveitis.
    Miserocchi E, Modorati G.
    Dev Ophthalmol; 2012 Jun; 51():98-109. PubMed ID: 22517208
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.
    Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, Bracaglia C, Shardlow A, Parentin F, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, De Marco R, Breda L, La Torre F, Vittadello F, Martini G, Zulian F.
    J Rheumatol; 2013 Jan; 40(1):74-9. PubMed ID: 23118110
    [Abstract] [Full Text] [Related]

  • 16. Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    J Rheumatol; 2016 Dec; 43(12):2183-2188. PubMed ID: 27633821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, Feldman BM, Laxer RM, Schneider R, Silverman ED.
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [Abstract] [Full Text] [Related]

  • 19. Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis.
    Zannin ME, Buscain I, Vittadello F, Martini G, Alessio M, Orsoni JG, Breda L, Rigante D, Cimaz R, Zulian F.
    Acta Ophthalmol; 2012 Feb; 90(1):91-5. PubMed ID: 20039849
    [Abstract] [Full Text] [Related]

  • 20. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis.
    Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH.
    Am J Ophthalmol; 2011 Feb; 151(2):217-22. PubMed ID: 21145533
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.